Clinical trial
The Reduction of Systemic Lupus Erythematosus Flares:Study PLUS
NCT00413361 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00413361 |
|---|---|
| Title | The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS |
| Official title | Study of the Reduction of Systemic Lupus Erythematosus Flares Through Adaptation of the Dosage of Hydroxychloroquine to Its Whole-blood Concentration. National Multicenter Randomized Prospective Study |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Sanofi-Synthelabo Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | versus hydroxychloroquine |
| Enrollment | 543 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Dec 19, 2006 |
| Last update posted | Jan 27, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: